2017 Global Overactive Bladder Treatment Industry Research Report
SKU ID :HCCResearch-11294109 | Published Date: 05-Dec-2017 | No. of pages: 140Description
The report provides a comprehensive analysis of the Overactive Bladder Treatment industry market by types, applications, players and regions. This report also displays the production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Overactive Bladder Treatment industry in USA, EU, China,India, Japan and other regions, and forecast to 2022, from 2017.
Market Analysis by Players
Astellas Pharma
Pfizer
Teva Pharmaceutical Industries Limited
Allergan
Medtronic
Mylan
Endo International
Hisamitsu Pharmaceutical
Sanofi
Aurobindo Pharma Limited
Apotex
Cogentix Medical
Market Analysis by Regions:
North America
Europe
China
Japan
India
Others
Market Analysis by Types:
Anticholinergic- Solifenacin
Oxybutynin
Fesoterodine
Darifenacin
Mirabegron
BOTOX
Neurostimulation
Market Analysis by Applications:
Idiopathic Bladder Overactivity
Neurogenic Bladder Overactivity
Market Analysis by Players
Astellas Pharma
Pfizer
Teva Pharmaceutical Industries Limited
Allergan
Medtronic
Mylan
Endo International
Hisamitsu Pharmaceutical
Sanofi
Aurobindo Pharma Limited
Apotex
Cogentix Medical
Market Analysis by Regions:
North America
Europe
China
Japan
India
Others
Market Analysis by Types:
Anticholinergic- Solifenacin
Oxybutynin
Fesoterodine
Darifenacin
Mirabegron
BOTOX
Neurostimulation
Market Analysis by Applications:
Idiopathic Bladder Overactivity
Neurogenic Bladder Overactivity
TOC
Tables & Figures
Companies
- PRICE
-
$4000$7000Buy Now